Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tividenofusp alfa (DNL310) for the treatment ...
Despite being generally forgiving in everyday interactions, driving can evoke extreme anger, leading to road rage incidents. Such behavior risks safety, distressing drivers and passengers, especially ...